AU2004251635A1 - Method of reducing the harmful effects of orally or transdermally delivered nicotine - Google Patents

Method of reducing the harmful effects of orally or transdermally delivered nicotine Download PDF

Info

Publication number
AU2004251635A1
AU2004251635A1 AU2004251635A AU2004251635A AU2004251635A1 AU 2004251635 A1 AU2004251635 A1 AU 2004251635A1 AU 2004251635 A AU2004251635 A AU 2004251635A AU 2004251635 A AU2004251635 A AU 2004251635A AU 2004251635 A1 AU2004251635 A1 AU 2004251635A1
Authority
AU
Australia
Prior art keywords
tobacco
nicotine
tsna
plant
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004251635A
Other languages
English (en)
Inventor
Mark Conkling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vector Tobacco Ltd
Original Assignee
Vector Tobacco Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vector Tobacco Ltd filed Critical Vector Tobacco Ltd
Publication of AU2004251635A1 publication Critical patent/AU2004251635A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/20—Biochemical treatment
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A24B15/243—Nicotine
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A24B15/245—Nitrosamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Nutrition Science (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
AU2004251635A 2003-06-04 2004-05-27 Method of reducing the harmful effects of orally or transdermally delivered nicotine Abandoned AU2004251635A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47594503P 2003-06-04 2003-06-04
US60/475,945 2003-06-04
PCT/US2004/016958 WO2005000352A1 (en) 2003-06-04 2004-05-27 Method of reducing the harmful effects of orally or transdermally delivered nicotine

Publications (1)

Publication Number Publication Date
AU2004251635A1 true AU2004251635A1 (en) 2005-01-06

Family

ID=33551567

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004251635A Abandoned AU2004251635A1 (en) 2003-06-04 2004-05-27 Method of reducing the harmful effects of orally or transdermally delivered nicotine

Country Status (10)

Country Link
US (1) US20060237025A1 (ja)
EP (1) EP1628681A4 (ja)
JP (1) JP2007528204A (ja)
KR (1) KR20060032141A (ja)
CN (1) CN1812811A (ja)
AR (1) AR044599A1 (ja)
AU (1) AU2004251635A1 (ja)
CA (1) CA2527648A1 (ja)
WO (1) WO2005000352A1 (ja)
ZA (1) ZA200510170B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006247739A1 (en) 2005-05-11 2006-11-23 Vector Tobacco Inc. Reduced risk tobacco products and methods of making same
AR066792A1 (es) * 2007-06-01 2009-09-09 Syngenta Participations Ag Metodo para la produccion comercial de plantas transgenicas
US7667106B2 (en) * 2007-11-06 2010-02-23 Alliance One International, Inc. Tobacco cultivar ‘AOB 175’
US7665472B2 (en) * 2007-11-06 2010-02-23 Alliance One International, Inc. Tobacco cultivar AOB 175 and products therefrom
WO2010046423A2 (en) 2008-10-22 2010-04-29 Basf Se Use of sulfonylurea herbicides on cultivated plants
WO2010046422A2 (en) 2008-10-22 2010-04-29 Basf Se Use of auxin type herbicides on cultivated plants
US20150250174A1 (en) 2012-10-01 2015-09-10 Basf Se Use of n-thio-anthranilamide compounds on cultivated plants
WO2014079820A1 (en) 2012-11-22 2014-05-30 Basf Se Use of anthranilamide compounds for reducing insect-vectored viral infections
CN103005703B (zh) * 2012-12-12 2015-04-15 广东中烟工业有限责任公司 一种基于烟气危害性指数的卷烟设计方法
CN103005702B (zh) * 2012-12-12 2015-03-18 广东中烟工业有限责任公司 一种深度抽吸下基于危害性指数的低危害卷烟设计方法
CN102940310B (zh) * 2012-12-12 2015-08-05 广东中烟工业有限责任公司 一种基于n-亚硝胺释放量的卷烟设计中各个组分的调整方法
EP3028573A1 (en) 2014-12-05 2016-06-08 Basf Se Use of a triazole fungicide on transgenic plants
WO2016091674A1 (en) 2014-12-12 2016-06-16 Basf Se Use of cyclaniliprole on cultivated plants
US11064696B2 (en) 2015-04-07 2021-07-20 Basf Agrochemical Products B.V. Use of an insecticidal carboxamide compound against pests on cultivated plants
EP3338552A1 (en) 2016-12-21 2018-06-27 Basf Se Use of a tetrazolinone fungicide on transgenic plants
WO2020003363A1 (ja) * 2018-06-25 2020-01-02 学校法人近畿大学 ニコチン摂取の影響による血管の劣化を防止するための健康食品または医薬組成物
WO2021072288A1 (en) * 2019-10-10 2021-04-15 Altria Client Services Llc Compositions and methods based on qpt engineering for producing tobacco plants and products having altered alkaloid levels
CN113528537A (zh) * 2021-08-11 2021-10-22 云南省烟草农业科学研究院 一种降低烟叶烟碱含量的NtQPT2基因突变体及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993005646A1 (en) * 1991-09-13 1993-04-01 Technology Management Services, S.A. Reduction of nicotine levels in tobacco
WO2000067558A1 (en) * 1999-05-06 2000-11-16 Michael Timko Regulation of gene expression in tobacco for manipulation of plant growth and secondary metabolism
WO2001059150A1 (en) * 2000-02-07 2001-08-16 Dos Remedios Cristobal Guiller Biomolecular toxicity assay
WO2002018607A2 (en) * 2000-08-30 2002-03-07 North Carolina State University Transgenic plants containing molecular decoys that alter protein content therein
EP1408780A2 (en) * 2000-11-10 2004-04-21 Vector Tobacco Ltd. Method and product for removing carcinogens from tobacco smoke
US20060157072A1 (en) * 2001-06-08 2006-07-20 Anthony Albino Method of reducing the harmful effects of orally or transdermally delivered nicotine
IL159213A0 (en) * 2001-06-08 2004-06-01 Vector Tobacco Ltd Modifying nicotine and nitrosamine levels in tobacco
AU2002340407A1 (en) * 2001-11-09 2003-05-26 Vector Tobacco Inc. Method and composition for mentholation of charcoal filtered cigarettes
EP1499188A4 (en) * 2002-04-09 2007-11-14 Vector Tobacco Ltd TOBACCO WITH A REDUCED NICOTINE AND NITROSAMINE CONTENT
US20050066986A1 (en) * 2003-09-30 2005-03-31 Nestor Timothy Brian Smokable rod for a cigarette

Also Published As

Publication number Publication date
EP1628681A4 (en) 2009-07-15
US20060237025A1 (en) 2006-10-26
AR044599A1 (es) 2005-09-21
EP1628681A1 (en) 2006-03-01
WO2005000352A1 (en) 2005-01-06
ZA200510170B (en) 2006-11-29
JP2007528204A (ja) 2007-10-11
KR20060032141A (ko) 2006-04-14
CN1812811A (zh) 2006-08-02
CA2527648A1 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
US11572568B2 (en) Regulating alkaloids
US6907887B2 (en) Modifying nicotine and nitrosamine levels in tobacco
US11667924B2 (en) Increasing levels of nicotinic alkaloids in plants
US20060237025A1 (en) Method of reducing the harmful effects of orally or transdermally delivered nicotine
EP2061889B1 (en) Increasing levels of nicotinic alkaloids
AU2002305874A1 (en) Modifying nicotine and nitrosamine levels in tobacco

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application